CLINICAL-DIAGNOSIS OF HETEROZYGOUS DYSTROPHIN GENE DELETIONS BY FLUORESCENCE IN-SITU HYBRIDIZATION

Citation
C. Rosenberg et al., CLINICAL-DIAGNOSIS OF HETEROZYGOUS DYSTROPHIN GENE DELETIONS BY FLUORESCENCE IN-SITU HYBRIDIZATION, Neuromuscular disorders, 8(7), 1998, pp. 447-452
Citations number
15
Categorie Soggetti
Neurosciences,"Clinical Neurology
Journal title
ISSN journal
09608966
Volume
8
Issue
7
Year of publication
1998
Pages
447 - 452
Database
ISI
SICI code
0960-8966(1998)8:7<447:COHDGD>2.0.ZU;2-Y
Abstract
Two-thirds of patients affected by Duchenne or Becker muscular dystrop hy (DMD/BMD) carry large intra-genic deletions in the dystrophin gene. In males, the deletions can be efficiently detected using multiplex p olymerase chain reaction (PCR) and Southern blotting. In contrast, del etion detection in carrier females is complicated by the presence of a normal gene copy on the second X-chromosome. We have analyzed the bou ndaries of 570 deletions and 34 duplications in the dystrophin gene id entified in the Sao Paulo and Leiden diagnostic laboratories. The data were used to select an optimal set of cosmid probes for the detection of the most frequently deleted areas of the dystrophin gene. Six cosm ids were evaluated in fluorescence in situ hybridization (FISH) experi ments to assess deletions in 21 heterozygous deletion-carriers and nin e controls. No discrepancy was found between the FISH analysis and the molecular data, demonstrating the accuracy of the technique for carri er detection in Duchenne and Becker muscular dystrophy. (C) 1998 Elsev ier Science B.V. All rights reserved.